Elevance Health Inc. has released the transcript of its Fourth Quarter 2025 earnings conference call, held on January 28, 2026. The event was attended by key members of the company’s leadership, including the President and Chief Executive Officer, the Chief Financial Officer, the Executive Vice President and President of Government Health Benefits, the Executive Vice President and President of Carelon and CarelonRx, and the Executive Vice President and President of Commercial and Specialty Business. Equity analysts from UBS AG, Jefferies LLC, Cantor Fitzgerald LP, and Deutsche Bank AG also participated in the call. During the call, Elevance Health’s management emphasized their ongoing commitment to affordability and improving health outcomes. “Affordability remains the central challenge in healthcare. At Elevance Health, our focus is on improving outcomes, making care easier to access and navigate, and managing costs responsibly,” stated the President and Chief Executive Officer. The company reiterated its strategy to improve affordability, simplify healthcare, and enhance access and experiences for members and care providers. Management expressed confidence in the company’s diversified platform and “whole health approach,” highlighting that these factors position Elevance Health for sustainable earnings growth in the long term. They also acknowledged the dynamic operating environment and advised listeners to review risk factors discussed in the press release and SEC filings. The full transcript can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevance Health Inc. published the original content used to generate this news brief on January 29, 2026, and is solely responsible for the information contained therein.